How Clovis Scored Big on a Milestone FDA Approval

0 Comments 1 view(s)

Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares climb late Tuesday after the company announced a key U.S. Food and Drug Administration (FDA) approval. Note that this is the first of a few…

Powered by WPeMatico